Warning letter · FDA Warning Letters

Sunshine Trading Company, Inc. dba Nova Tea and Nova Kratom: FDA Warning Letter 660633 (Jul 3, 2023)

Agency action: Jul 3, 2023Record ID: fda_warning_-887c24c8462a1348
View official source ↗

What happened

Original notice title

Sunshine Trading Company, Inc. dba Nova Tea and Nova Kratom MARCS-CMS 660633, July 03, 2023

From the archived source record

Based on our review, these products are unapproved new drugs under section 505(a) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. 355(a). The marketing and sale of unapproved opioid addiction treatment products is a potentially significant threat to the public health. Unapproved New Drugs Your kratom products are drugs under section 201(g)(1) of the FD&C Act, 21 U.S.C. 321(g)(1), because they are intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, and/or intended to affect the structure or any function of the body. This letter is not intended to be an all-inclusive statement of violations that may exist in connection with your products. You are responsible for investigating and determining the causes of any violations and for preventing their recurrence or the occurrence of other violations. This letter notifies you of our concerns and provides you an opportunity to address them. Failure to adequately address this matter may result in legal action including, without limitation, seizure and injunction. Please notify FDA in writing, within fifteen working days of receipt of this letter, of the specific steps you have taken to correct these violations. Include an explanation of each step being taken to prevent the recurrence of violations, as well as copies of related documentation. If you believe that your products are not in violation of the FD&C Act, include your reasoning and any supporting information for our consideration. Food and Drug Administration, CDER/OC/Office of Unapproved Drugs and Labeling Compliance, by email to FDAAdvisory@fda.hhs.gov.

What the official notice says to do

Check the original notice for the instructions that apply to the named product, company, and affected lots.

Read the official notice →

Status and source details

Status recorded in the archive
No closeout listed in FDA table
Source checked
Jul 16, 2026
Record revision
42cb5c64f36f

This is a dated record. Its current status may have changed since the source was captured. A record applies to its stated scope; it is not a safety rating for every product from a company.

Sources, dates, and coverage →

What is affected

Product
Green Maeng Da Kratom Powder; Green Malay Kratom Powder; Red Bali Kratom Powder; Yellow Vietnam Kratom Powder; White Borneo Kratom Powder; 7-hydroxymitragynine
Company
Sunshine Trading Company, Inc. dba Nova Tea and Nova Kratom
Lot / identifier
The source does not specify this field.
Market / distribution
The source does not specify this field.